You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cardiovascular conditions
  5. Embolism and thrombosis

Dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation

  • Technology appraisal guidance
  • Reference number: TA249
  • Published:  15 March 2012
  • Last updated:  02 July 2021
  • Guidance
  • Tools and resources
  • Information for the public
  • History

Atrial fibrillation - dabigatran etexilate: appeal from NHS Salford

  • Atrial fibrillation - dabigatran etexilate: NHS Salford - appeal received

  • Atrial fibrillation - dabigatran etexilate: NHS Salford - initial scrutiny letter

  • Atrial fibrillation - dabigatran etexilate: NHS Salford - response to scrutiny letter

  • Atrial fibrillation - dabigatran etexilate: NHS Salford - final scrutiny letter


This page was last updated: 03 February 2012

Back to top